BLCO
Price
$21.33Alerts
Change
-$0.04 (-0.19%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
7.14B
105 days until earnings call
Intraday BUY SELL Signals
RVTY
Price
$158.21Alerts
Change
-$0.89 (-0.56%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
17.31B
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLCO vs RVTY

BLCO vs RVTY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BLCO vs. RVTY commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLCO is a Buy and RVTY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BLCO with price predictions
Nov 10, 2026

BLCO in upward trend: 10-day moving average moved above 50-day moving average on October 28, 2026

The 10-day moving average for BLCO crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on BLCO as a result. In 72 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for BLCO just turned positive on October 21, 2026. Looking at past instances where BLCO's MACD turned positive, the stock continued to rise in 34 of 49 cases over the following month. The odds of a continued upward trend are 69%.

BLCO moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLCO advanced for three days, in 164 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 77 of 111 cases where BLCO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLCO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

BLCO broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.120) is normal, around the industry mean (4.964). P/E Ratio (-41.646) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.888) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.139) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. BLCO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLCO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for RVTY with price predictions
Nov 10, 2026

RVTY's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for RVTY moved out of overbought territory on October 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In 23 of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RVTY as a result. In 61 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for RVTY turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 33 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

RVTY broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 67 cases where RVTY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

Following a +6.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where RVTY advanced for three days, in 200 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

The Aroon Indicator entered an Uptrend today. In 113 of 187 cases where RVTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 2 (best 1 - 100 worst), indicating outstanding price growth. RVTY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.394) is normal, around the industry mean (67.298). P/E Ratio (74.572) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (3.473). Dividend Yield (0.002) settles around the average of (0.002) among similar stocks. P/S Ratio (5.656) is also within normal values, averaging (9.775).

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVTY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

FUNDAMENTALS RATINGS
RVTY: Fundamental Ratings
RVTY
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
2
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLCORVTY
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend about 1 month ago
67%
Bearish Trend 7 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
60%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BLCO: $21.37 vs. RVTY: $159.10)
Brand notoriety: BLCO and RVTY are both not notable
BLCO represents the Pharmaceuticals: Other, while RVTY is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLCO: 208% vs. RVTY: 56%
Market capitalization -- BLCO: $7.14B vs. RVTY: $17.31B
BLCO [@Pharmaceuticals: Other] is valued at $7.14B. RVTY’s [@Medical Specialties] market capitalization is $17.31B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLCO’s FA Score shows that 1 FA rating(s) are green while RVTY’s FA Score has 2 green FA rating(s).

  • BLCO’s FA Score: 1 green, 4 red.
  • RVTY’s FA Score: 2 green, 3 red.
According to our system of comparison, both BLCO and RVTY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLCO’s TA Score shows that 6 TA indicator(s) are bullish while RVTY’s TA Score has 3 bullish TA indicator(s).

  • BLCO’s TA Score: 6 bullish, 4 bearish.
  • RVTY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BLCO is a better buy in the short-term than RVTY.

Price Growth

BLCO (@Pharmaceuticals: Other) experienced а +6.69% price change this week, while RVTY (@Medical Specialties) price change was -2.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.92%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +38.31%.

Reported Earning Dates

BLCO is expected to report earnings on Feb 24, 2027.

RVTY is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+1.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-4.92% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

BLCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLCO has been loosely correlated with COO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BLCO jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLCO
1D Price
Change %
BLCO100%
+1.96%
COO - BLCO
45%
Loosely correlated
-0.56%
ICUI - BLCO
45%
Loosely correlated
+1.82%
CRL - BLCO
45%
Loosely correlated
-2.13%
MTD - BLCO
44%
Loosely correlated
-0.62%
RVTY - BLCO
44%
Loosely correlated
-1.01%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been closely correlated with TMO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
-1.01%
TMO - RVTY
70%
Closely correlated
-0.48%
A - RVTY
64%
Loosely correlated
-1.27%
AZTA - RVTY
63%
Loosely correlated
-1.15%
WAT - RVTY
62%
Loosely correlated
-0.25%
BIO - RVTY
60%
Loosely correlated
-0.47%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TOT24.04N/A
N/A
LionShares U.S. Equity Total Return ETF (TOT)
WEEK100.00-0.06
-0.06%
Roundhill Weekly T-Bill ETF
FSMB19.83-0.02
-0.10%
First Trust Short Duration Managed Municipal ETF (FSMB)
ACEI22.83-0.08
-0.35%
Innovator Equity Autocallable Income Strategy ETF
MGC274.37-1.22
-0.44%
Vanguard Morningstar Mega Cap ETF (MGC)